NCT01291199View on ClinicalTrials.gov

Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

April 30, 2010

Conditions
Raynaud Syndrome
Interventions
DRUG

vardenafil

10 mg p.o. bid for 6 weeks

DRUG

Placebo

Placebo p.o. 6 weeks bid

Trial Locations (1)

50924

University of Cologne - Heart Center, Cologne

All Listed Sponsors
lead

University of Cologne

OTHER

NCT01291199 - Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome | Biotech Hunter | Biotech Hunter